Robert Langer receives Kyoto Prize
Institute Professor cited as "a founder of the field of tissue engineering."
Koch Institute
Faculty highlight: Paula Hammond
Engineering tiny paths to cancer treatment, bone regrowth, and wound healing, Paula Hammond serves as an exemplary researcher-educator within the MIT community.
Expanding the power of RNA interference
RNA carried by new nanoparticles can silence genes in many organs, could be deployed to treat cancer.
Chemotherapy timing is key to success
Nanoparticles that stagger delivery of two drugs knock out aggressive tumors in mice.
Fast way to measure DNA repair
Test analyzing cells’ ability to fix different kinds of broken DNA could help doctors predict cancer risk.
Making cancer drugs better
Killian Award recipient Stephen Lippard describes his work on platinum-based chemotherapy agents.
How to build a biotech renaissance: MIT in Kendall Square
A look back at how Institute Professor Phillip Sharp, his startup Biogen, and MIT’s biotech community helped revive Kendall Square.
New view of tumors’ evolution
Sequencing of cancer cell genomes reveals potential new drug targets for an aggressive type of lung cancer.
How the immune system fights off malaria
Study reveals immune cells that are critical to combating the parasite in early stages of infection.
Ludwig Cancer Research gives $90 million to MIT
MIT is one of six institutions receiving a total of $540 million to provide reliable, long-term support for high-impact, innovative research.
Researchers unlock a new means of growing intestinal stem cells
Studying these cells could lead to new treatments for diseases ranging from gastrointestinal disease to diabetes.
Biologists ID new cancer weakness
Drugs that block new target gene could make many tumors more vulnerable to chemotherapy.